| BGGL-0001 |
| 851608-39-4 |
| C59H108N2O22 |
| 1197.51 |
| N-[(1S,2R,3E)-2- hydroxy-1-[[[O-[N-(2→3)-O-β-D- galactopyranosyl- (1→4)-β-D- glucopyranosyl]oxy| methyl]-3- heptadecen-1-yl]- Octadecanamide |
| Neu5Gcx2,3Galβ1,4Glc Ceramide |
| Min 95% |
| 10mg 2mg 5mg |
| BGGL-0001 |
| 851608-39-4 |
| C59H108N2O22 |
| 1197.51 |
| N-[(1S,2R,3E)-2- hydroxy-1-[[[O-[N-(2→3)-O-β-D- galactopyranosyl- (1→4)-β-D- glucopyranosyl]oxy| methyl]-3- heptadecen-1-yl]- Octadecanamide |
| Neu5Gcx2,3Galβ1,4Glc Ceramide |
| Min 95% |
| 10mg 2mg 5mg |